Daniel sat down with Bob Wachter to talk about the power of Twitter in public health, the continued evolution of patient-centered digital transformation, the very necessary adjustments to clinical education, his personal history as the founder of the hospitalist movement, and which technologies continue to lag in our industry.
Dr. Joanne Armstrong, Vice President and Chief Medical Officer for women's health and genomics at CVS Health, talks with Daniel about the incredible impact genes can play in women’s lives, helping to shape prognosis and clinical decisions, in addition to improvements in prenatal screening. Dr. Armstrong also gives us a preview of Aetna’s new guided genetic health services — now expanding into enhanced maternity and transform oncology programs.
Daniel explores the exciting world of genetic health with Dr. Robert Nussbaum, Chief Medical Officer at Invitae. Dr. Nussbaum dispels myths about interpreting genetic data, draws important distinctions around clinical-grade testing, and describes the many important ways genetic information can be used for reproductive planning, screening, and managing disorders.
The past few years may have been challenging but they’ve also brought about transformation in the pharmacy setting. Daniel speaks with Dr. Dan Knecht, the chief clinical innovation officer at CVS Caremark, about ways he’s working to provide more integrative, individualized care for patients with conditions like diabetes, heart disease, and hypertension — as well as behavioral health.
While 2021 has been a rollercoaster year, Daniel was able to cover plenty of exciting and innovative topics. He sat down with experts in public health data (discovering the data supply chain), precision oncology care, functional medicine, cutting edge red blood cell research, a venture capitalist, a former CEO and more. Health care and health care innovation is going to continue to accelerate in 2022 as the industry evolves from “intermittent, reactive sick care to a future that's continuous, pr...
Daniel speaks with award-winning filmmaker Matthew Heineman, who had exclusive access in March 2020 to one of New York’s largest and hardest-hit medical centers for his powerful documentary, The First Wave — as well as Dr. Nathalie Dougé, internist & hospitalist — about the toll COVID has taken on health care workers. The film is in theaters now and available on Hulu.
Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells — membrane stability, abnormalities, stickiness, and more. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.
Some 100,000 individuals in America alone are dealing with sickle cell. Daniel speaks with Joel Helle, Vice President of Physician Services for CVS Health, about how to change the often one-size-fits-all approach to this painful disease — to care that is not only more continuous, but personalized, and proactive.
Dr. Nitin Gupta is the founder of Rivertowns Pediatrics, a very different type of private practice. Having practiced from Newark, NJ to Caribou, ME, he’s landed on a value-based, concierge model that works. Boiling things down, Dr. Gupta told Daniel, “You're spending more time on that computer than you are face to face with that patient. This gives you the opportunity to be the doctor that you were meant to be, and so that's why I started this.”
Daniel sits down with Dr. Kim Blackwell, former oncologist and Eli Lilly trialist who is now the Chief Medical Officer at Tempus, a technology company that has built the world's largest library of clinical and molecular data as well as an operating system to make that information accessible and useful for patients, physicians, and researchers. They discuss big data, genetic sequencing, and the tech that drives today’s transformative precision cancer treatments.
Daniel sits down with Dr. Pat Basu, President & CEO of Cancer Treatment Centers of America, to discuss his unique point of view on the evolution of oncology care, precision medicine, the changing role of MD MBAs like himself, his early telemedicine work with Doctor On Demand, as well as his time as a Fellow advising the White House.
Daniel sits down with Dr. Mark Hyman, Head of Strategy & Innovation at the Cleveland Clinic Center for Functional Medicine – “a paradigm shift in our thinking about disease.” Dr. Hyman says, “We've now got 155,000 diseases in our diagnostic category book, but they're really all driven by a smaller number of common root causes.”
Daniel sits down with Dr. Robert Pearl, former surgeon and CEO at Permanente Medical Group for 18 years, about the culture of medicine and his new book Uncaring: How the Culture of Medicine Kills Doctors & Patients (proceeds go to Doctors Without Borders). Dr. Pearl provides an unflinching diagnosis of “physician culture” dating back to Dr. Ignaz Semmelweis’ battered leather apron in 1844; second, he details the escalating costs of healthcare; and third, he addresses the danger of implicit b...
Daniel is a physician who wears many hats: inventor, founder, investor, and startup advisor. This week he sat down with another physician, Dr. Vineeta Agarwala, who has taken her clinical expertise to a whole other industry. Vineeta is a General Partner at Andreessen Horowitz, where she leads investments for the storied firm’s bio fund (overseeing therapeutics, diagnostics, and digital health).
Daniel sat down with Dr. Dylan George, a biosecurity and data expert from Gingko Bioworks. Dylan’s career spans academia and a number of roles in the federal government — advising the Obama administration on Ebola and, more recently, advising the Biden-Harris transition team on COVID-19. If data is the new oil, it's also the new way of protecting our kids, our families, and our communities.
May is Women’s Health month, and Daniel sat down with Dr. Joanne Armstrong, Chief Medical Officer for Women's Health & Genomics at CVS Health, for both a tactical and macro-level look at how we all measure up to the rest of the world in this area — including prenatal, maternal, and postpartum care, as well as breast cancer and the latest studies on unconscious bias.
Daniel speaks with Dr. Laurie Zephyrin, VP of Health Systems Equity at the Commonwealth Fund. Laurie was a key player in transforming women’s health at the VA, having trained as an OB-GYN before scaling her attention to systems, structures and culture.
Daniel speaks with Dr. Sree Chaguturu, Chief Medical Officer, CVS Caremark about vaccine hesitancy — citing original research around common objections and physician best practices — as well as current vaccination rates, variants and boosters, and what we’ve learned as an enterprise from long term care (LTC) facilities and the federal retail pharmacy program.
In this episode, we explore the latest thinking and newest innovations in at-home care for seniors. Guests include AgeWave founders,Doctors Ken and Maddy Dychtwald, our own Adam Pellegrini (SVP Enterprise Virtual Care & Consumer Health), and health care futurist Zayna Khayat (author of The Future of Aging).
We also connected with Dr. Kenneth Snow about innovative technologies like CGM (continuous glucose monitors), early detection, and the fine line between giving patients more autonomy and the risk of overwhelming them. Lastly, we’ll hear from Rebecca Rice, pharmacist and educator, about the evolving role she plays in the life of chronic care patients via the unique HealthHub model.
There might not be a specific moment when we can hit the reset button and start to tackle systemic healthcare challenges with a clean slate, but smaller resets are already underway. Join us as we examine what a COVID-19 Reset looks like for doctors, nurses, and other healthcare professionals. In this episode, we spoke with Dr. Rushika Fernandopulle, founder and CEO of Iora Health, about how physicians have addressed the pandemic in their own practices and the changing perceptions around value ba...
In the second episode of Healthy Conversations — an open discussion among healthcare professionals about innovation, what we're learning on the front lines of this pandemic, and how our industry is changing in real time — we turn our attention to Recovery. Data is critical in addressing the challenges of COVID-19 and influences so many of our daily, clinical decisions. How will big data, more specifically “distilling multiple biometric data streams,” transform medicine moving forward? Join our h...
In the first of three COVID-19-focused episodes, listen in on robust discussions with CVS Health leaders and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, as they discuss the importance of testing, as well as how systemic racism is impacting the pandemic response.
